Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02900781 · ClinicalTrials.gov registry record · NA

Comparative Effectiveness of an Activity-specific Monitoring Device- StepRite

A NA study, sponsored by Texas Tech University Health Sciences Center.

Terminated
Registry status
NA
Development phase
9
Enrollment target

NCT02900781: Clinical Trial NA study, sponsored by Texas Tech University Health Sciences Center.

NCT02900781 is a NA study that was terminated before completion, run by Texas Tech University Health Sciences Center. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02900781, a NA study, was terminated before completion, sponsored by Texas Tech University Health Sciences Center.

TERMINATED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

Partial or Total Knee Arthroplasty are procedures commonly used in severe degeneration of the knee joint due to osteoarthritis. With an increasing number of Partial or Total Knee Arthroplasty performed in a population that is aging during a time where the amount of healthcare dollars allotted to rehabilitation is declining, there is a need to develop remote monitoring of rehabilitation and to engage and optimize self-management of recovery. Current management of Partial or Total Knee Arthroplasty recovery is typically performed in the out-patient setting and is highly protocol driven. A typical case might be seen by the physical therapist 2-3x/week for 8-10 weeks to perform specific exercises and to monitor progress (i.e. compliance with ROM and strengthening exercises). One recent study suggested that variation in patients' independent exercise and activity after arthroplasty surgery may contribute to variable functional gains. The investigators are proposing that the StepRite device developed by MedHab, (a shoe insert that collects functional data) will reduce cost and improve the efficacy of rehabilitation in total knee arthroplasty patients

Primary Outcome

Effectiveness of outcomes with the use of the StepRite device

Interventions

  • OTHER Standard of care
  • DEVICE Steprite™

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2016-10-21
Est. Completion 2017-11
Phase NA

Why NCT02900781 stopped before completion

NCT02900781 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard of care is the first listed.

NCT02900781 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02900781 about?

NCT02900781 is a clinical study titled "Comparative Effectiveness of an Activity-specific Monitoring Device- StepRite". Partial or Total Knee Arthroplasty are procedures commonly used in severe degeneration of the knee joint due to osteoarthritis. With an increasing number of Partial or Total Knee Arthroplasty performed in a population that is aging during a time where the amount of healthcare dollars allotted to reh...

What is the current status of trial NCT02900781?

This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2016-10-21. Estimated completion is 2017-11.

What interventions are being tested in trial NCT02900781?

The interventions under investigation include: Standard of care (OTHER), Steprite™ (DEVICE).

Who is sponsoring clinical trial NCT02900781?

This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02900781's enrollment target sits among peer trials

9 1975th of 2000 higher than 25 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02900781, the US trial registry maintained by the National Library of Medicine. NCT02900781 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.